TY - CHAP M1 - Book, Section TI - Treatment of Hypertension A1 - Eschenhagen, Thomas A2 - Brunton, Laurence L. A2 - Hilal-Dandan, Randa A2 - Knollmann, Björn C. PY - 2017 T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e AB - AbbreviationsACE: angiotensin-converting enzymeACEI: angiotensin-converting enzyme inhibitorAldo: aldosteroneAngII: angiotensin IIANP: atrial natriuretic peptideARB: angiotensin receptor blockerAT1: type 1 receptor for angiotensin IIATPase: adenosine triphosphataseAV: atrioventricularBB: β blockerβ blocker: β adrenergic receptor antagonistBNP: brain natriuretic peptideBP: blood pressureCAD: coronary artery diseaseCCB: Ca2+ channel blockerCNS: central nervous systemCOX-2: cyclooxygenase 2DOPA: 3,4-dihydroxyphenylalanineDRI: direct renin inhibitorENaC: epithelial Na+ channelESC: European Society of CardiologyGI: gastrointestinalGFR: glomerular filtration rateHDL: high-density lipoproteinHF: heart failureHTN: hypertensionISA: intrinsic sympathomimetic activityISDN: isosorbide dinitrateJNC8: Eighth Joint National CommitteeMI: myocardial infarctionMRA: mineralocorticoid receptor antagonistNCC: NaCl cotransporterNE: norepinephrineNO: nitric oxideNSAID: nonsteroidal anti-inflammatory drugRAAS: renin-angiotensin-aldosterone systemRAS: renin-angiotensin systemSA: sinoatrialSNS: sympathetic nervous systemVMAT2: vesicular catecholamine transporter 2 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/14 UR - accessmedicine.mhmedical.com/content.aspx?aid=1162538308 ER -